• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Developing process measures in value-based healthcare: the case of aortic valve disease.基于价值的医疗保健中制定过程指标:以主动脉瓣疾病为例。
BMJ Open Qual. 2019 Nov 7;8(4):e000716. doi: 10.1136/bmjoq-2019-000716. eCollection 2019.
2
Outcomes of intermediate-risk patients treated with transcatheter and surgical aortic valve replacement in the Veterans Affairs Healthcare System: A single center 20-year experience.退伍军人事务医疗系统中接受经导管和外科主动脉瓣置换术治疗的中度风险患者的结局:单中心20年经验
Catheter Cardiovasc Interv. 2018 Aug 1;92(2):390-398. doi: 10.1002/ccd.27478. Epub 2018 Jan 9.
3
Computed Tomography-Based Indexed Aortic Annulus Size to Predict Prosthesis-Patient Mismatch.基于计算机断层扫描的主动脉瓣环大小指数预测人工瓣膜-患者不匹配。
Circ Cardiovasc Interv. 2019 Apr;12(4):e007396. doi: 10.1161/CIRCINTERVENTIONS.118.007396.
4
A Comparative Study of TAVR versus SAVR in Moderate and High-Risk Surgical Patients: Hospital Outcome and Midterm Results.中高危手术患者经导管主动脉瓣置换术与外科主动脉瓣置换术的比较研究:医院结局和中期结果
Heart Surg Forum. 2019 Aug 27;22(5):E331-E339. doi: 10.1532/hsf.2243.
5
Self-Expanding Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Patients at High Risk for Surgery: A Study of Echocardiographic Change and Risk Prediction.高危手术患者中经导管主动脉瓣自膨胀置换术与外科瓣膜置换术的比较:一项关于超声心动图变化及风险预测的研究
Circ Cardiovasc Interv. 2016 Jun;9(6). doi: 10.1161/CIRCINTERVENTIONS.115.003426.
6
In-hospital outcomes after transcatheter or surgical aortic valve replacement in younger patients less than 75 years old: a propensity-matched comparison.75 岁以下年轻患者行经导管主动脉瓣置换术或外科主动脉瓣置换术后的院内转归:倾向评分匹配比较。
EuroIntervention. 2018 May 20;14(1):50-57. doi: 10.4244/EIJ-D-17-01051.
7
Transcatheter Aortic Valve Replacement is Associated with Comparable Clinical Outcomes to Open Aortic Valve Surgery but with a Reduced Length of In-Patient Hospital Stay: A Systematic Review and Meta-Analysis of Randomised Trials.经导管主动脉瓣置换术与开放性主动脉瓣手术的临床结局相当,但住院时间缩短:一项随机试验的系统评价和荟萃分析。
Heart Lung Circ. 2017 Mar;26(3):285-295. doi: 10.1016/j.hlc.2016.07.011. Epub 2016 Aug 29.
8
Hospital outcomes of transcatheter versus surgical aortic valve replacement in female in the United States.美国女性经导管主动脉瓣置换术与外科主动脉瓣置换术的医院治疗结果
Catheter Cardiovasc Interv. 2018 Mar 1;91(4):813-819. doi: 10.1002/ccd.27362. Epub 2017 Oct 9.
9
Trends in volume and risk profiles of patients undergoing isolated surgical and transcatheter aortic valve replacement.接受单纯外科主动脉瓣置换术和经导管主动脉瓣置换术患者的手术量及风险特征趋势
Catheter Cardiovasc Interv. 2019 May 1;93(6):E337-E342. doi: 10.1002/ccd.27855. Epub 2018 Sep 30.
10
Comparative Outcomes of Surgical and Transcatheter Aortic Valve Replacement for Aortic Stenosis in Nonagenarians.非agenarians主动脉瓣狭窄患者外科手术与经导管主动脉瓣置换术的比较结果。 注:这里“Nonagenarians”指的是九十多岁的人,可根据实际语境调整表述,比如“九十多岁的老年患者” 。
Am J Cardiol. 2017 Mar 15;119(6):893-899. doi: 10.1016/j.amjcard.2016.11.045. Epub 2016 Dec 18.

引用本文的文献

1
Quality measurement for cardiovascular diseases and cancer in hospital value-based healthcare: a systematic review of the literature.医院价值医疗中心血管疾病和癌症的质量测量:文献系统评价。
BMC Health Serv Res. 2022 Aug 1;22(1):979. doi: 10.1186/s12913-022-08347-x.
2
Articulation of postsurgical patient discharges: coordinating care transitions from hospital to home.术后患者出院的协调:从医院到家庭的护理交接。
J Am Med Inform Assoc. 2022 Aug 16;29(9):1546-1558. doi: 10.1093/jamia/ocac099.
3
Patient Perspectives on Key Outcomes for Vocational Rehabilitation Interventions Following Traumatic Injury.创伤后职业康复干预关键结局的患者观点。
Int J Environ Res Public Health. 2021 Feb 19;18(4):2035. doi: 10.3390/ijerph18042035.
4
Quality of life in sexagenarians after aortic biological vs mechanical valve replacement: a single-center study in China.主动脉生物瓣膜置换与机械瓣膜置换术后老年患者的生活质量:一项中国单中心研究
J Cardiothorac Surg. 2020 May 12;15(1):88. doi: 10.1186/s13019-020-01143-w.

本文引用的文献

1
Unlocking the potential of value-based health care by defining global standard sets of outcome measures that matter to patients with cardiovascular diseases.通过定义对心血管疾病患者有意义的全球通用结局指标标准集,挖掘以价值为基础的医疗保健的潜力。
Eur Heart J Qual Care Clin Outcomes. 2019 Apr 1;5(2):92-95. doi: 10.1093/ehjqcco/qcy056.
2
Quality of Care for Transcatheter Aortic Valve Implantation: Development of Canadian Cardiovascular Society Quality Indicators.经导管主动脉瓣植入术的护理质量:加拿大心血管学会质量指标的制定。
Can J Cardiol. 2016 Aug;32(8):1038.e1-4. doi: 10.1016/j.cjca.2015.11.008. Epub 2015 Nov 14.
3
Redefining global health-care delivery.重新定义全球医疗保健服务。
Lancet. 2013 Sep 21;382(9897):1060-9. doi: 10.1016/S0140-6736(13)61047-8. Epub 2013 May 20.
4
Aortic valve and ascending aorta guidelines for management and quality measures: executive summary.主动脉瓣和升主动脉管理及质量措施指南:执行摘要。
Ann Thorac Surg. 2013 Apr;95(4):1491-505. doi: 10.1016/j.athoracsur.2012.12.027. Epub 2013 Jan 2.
5
Transcatheter aortic valve implantation: assessing the learning curve.经导管主动脉瓣植入术:评估学习曲线。
JACC Cardiovasc Interv. 2012 Jan;5(1):72-9. doi: 10.1016/j.jcin.2011.09.014. Epub 2011 Dec 21.
6
What is value in health care?医疗保健中的价值是什么?
N Engl J Med. 2010 Dec 23;363(26):2477-81. doi: 10.1056/NEJMp1011024. Epub 2010 Dec 8.
7
Association of surgical care improvement project infection-related process measure compliance with risk-adjusted outcomes: implications for quality measurement.外科手术护理改进项目感染相关过程指标符合风险调整结果的关联性:对质量测量的启示。
J Am Coll Surg. 2010 Dec;211(6):705-14. doi: 10.1016/j.jamcollsurg.2010.09.006.
8
Value-based health care delivery.基于价值的医疗服务提供。
Ann Surg. 2008 Oct;248(4):503-9. doi: 10.1097/SLA.0b013e31818a43af.
9
Predictive models for thoracic aorta surgery. Is the Euroscore the optimal risk model in the Netherlands?
Interact Cardiovasc Thorac Surg. 2005 Dec;4(6):538-42. doi: 10.1510/icvts.2005.108761. Epub 2005 Jul 22.
10
Measuring the quality of surgical care: structure, process, or outcomes?衡量外科护理质量:结构、过程还是结果?
J Am Coll Surg. 2004 Apr;198(4):626-32. doi: 10.1016/j.jamcollsurg.2003.11.017.

基于价值的医疗保健中制定过程指标:以主动脉瓣疾病为例。

Developing process measures in value-based healthcare: the case of aortic valve disease.

作者信息

Akmaz Berdel, Zipfel Nina, Bal Roland A, Rensing Benno J W M, Daeter Edgar J, van der Nat Paul B

机构信息

Department of Value-Based Healthcare, Sint Antonius Hospital, Nieuwegein, The Netherlands.

Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.

出版信息

BMJ Open Qual. 2019 Nov 7;8(4):e000716. doi: 10.1136/bmjoq-2019-000716. eCollection 2019.

DOI:10.1136/bmjoq-2019-000716
PMID:31799447
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6863668/
Abstract

BACKGROUND

As process measures can be means to change practices, this article presents process measures that impact on outcome measures for surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR) within value-based healthcare.

METHODS

Desk research and observations of patient trajectories were performed to map the processes involved in TAVR and SAVR. Semistructured interviews were conducted with healthcare professionals (n=8) and patients (n=2) to explore which processes were most important in relation to a standard set of outcome measures that was already monitored. Additionally, open interviews (n=2) were held to prioritise results. A focus group was performed for validation of the formulated process measures. Numerical data for these measures was not collected.

RESULTS

Process maps of the full cycle of care of TAVR and SAVR treatments in theory and in practice were developed. 28 processes were found important by interview participants due to their expected impact on patient-relevant outcomes. Seven processes were prioritised to be most important and were formulated into 12 process measures for both TAVR and SAVR: 'Number of times that deficient information provision to SAVR patients causes negative outcomes', 'Type of TAVR/SAVR prosthesis', 'Brand of TAVR prosthesis', 'Number of times the frailty score of a TAVR/SAVR patient >75 years is measured', 'Time between TAVR/SAVR surgery indication and surgery', 'Number of times that anticoagulants are stopped within 3 days before surgery', 'Time in hours between TAVR/SAVR surgery and permanent pacemaker implantation' and 'Percentage of standardised pain measurements'.

CONCLUSION

This study proposes an addition of select process measures to standard sets of outcome measures to improve healthcare quality. It illustrates a clear method for identifying process measures with impact on health outcomes in the future.

摘要

背景

由于过程指标可以作为改变医疗行为的手段,本文介绍了在基于价值的医疗保健中,对外科主动脉瓣置换术(SAVR)和经导管主动脉瓣置换术(TAVR)的结果指标有影响的过程指标。

方法

通过案头研究和对患者病程的观察,梳理TAVR和SAVR所涉及的流程。对医疗保健专业人员(n = 8)和患者(n = 2)进行了半结构化访谈,以探讨哪些流程对于已监测的一组标准结果指标最为重要。此外,还进行了开放式访谈(n = 2)以对结果进行优先级排序。开展了一次焦点小组讨论以验证所制定的过程指标。未收集这些指标的数值数据。

结果

绘制了理论和实践中TAVR和SAVR治疗全程护理的流程图。访谈参与者发现28个流程因其对患者相关结果的预期影响而很重要。七个流程被确定为最重要的流程,并被制定为TAVR和SAVR的12个过程指标:“向SAVR患者提供不足信息导致负面结果的次数”、“TAVR/SAVR假体类型”、“TAVR假体品牌”、“对年龄>75岁的TAVR/SAVR患者进行衰弱评分的次数”、“TAVR/SAVR手术指征与手术之间的时间”、“术前3天内停用抗凝剂的次数”、“TAVR/SAVR手术与永久起搏器植入之间的小时数”以及“标准化疼痛测量的百分比”。

结论

本研究建议在标准结果指标集中增加选定的过程指标,以提高医疗质量。它阐明了一种在未来识别对健康结果有影响的过程指标的清晰方法。